Medicare Enrolled

Dr. Shannon Garitty, MD

Pain Medicine · Waco, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
205 WOODHEW DR STE 220, Waco, TX 76712
2542459175
In practice since 2013 (12 years)
NPI: 1629414065 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garitty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garitty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garitty

Dr. Shannon Garitty is a pain medicine specialist in Waco, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Garitty performed 5,643 Medicare services across 2,406 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garitty received a total of $61,830 from 28 pharmaceutical and/or device companies across 922 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garitty is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 10% volume in TX $61,830 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,643
Medicare services
Top 10% in TX for pain medicine
2,406
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~470 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid) 1,362 $0 $5
Office visit, established patient (30-39 min) 1,248 $87 $316
Joint lubricant injection (TriVisc) 1,126 $7 $26
Drug screening test 305 $60 $350
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 270 $194 $497
Aspiration and/or injection of fluid large joint using ultrasound guidance 111 $71 $226
Injection, ketorolac tromethamine, per 15 mg 101 $0 $3
Testing for presence of drug, read by direct observation 76 $12 $50
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 69 $242 $617
Insertion of spinal neurostimulator electrode array through skin 68 $233 $5,675
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint 62 $43 $413
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint 58 $140 $989
Office visit, established patient (20-29 min) 58 $64 $220
New patient office visit (45-59 min) 55 $114 $408
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 51 $153 $391
Ultrasonic guidance for needle placement 49 $42 $133
Injection of upper or middle spine facet joint using imaging guidance, single level 48 $78 $455
Injection of upper or middle spine facet joint using imaging guidance, second level 48 $45 $288
Drug injection, under skin or into muscle 35 $10 $60
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint 33 $50 $453
Contrast dye for imaging, lower concentration 32 $0 $5
Injection of substance into middle or upper spine canal using imaging guidance 31 $61 $635
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance 30 $55 $387
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level 29 $84 $584
Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones 29 $337 $1,097
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint 29 $142 $1,000
Injection of substance into lower spine canal using imaging guidance 28 $68 $627
Insertion of spinal neurostimulator generator or receiver 25 $181 $819
Destruction of peripheral nerve or branch 25 $157 $574
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose 25 $60 $200
Injection of lower or sacral spine facet joint using imaging guidance, single level 21 $123 $436
Insertion of peripheral nerve neurostimulator electrode through skin 21 $203 $5,234
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level 19 $39 $261
Injection of lower or sacral spine facet joint using imaging guidance, second level 19 $69 $225
Fusion of spine in lower back 12 $1,197 $3,789
Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve 12 $53 $205
Fluoroscopic guidance for needle placement 12 $19 $271
Destruction of nerves supplying joint between spine and pelvis using imaging guidance 11 $147 $1,182
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
57.9% medium
41.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$61,830
Total received (2018-2024)
Avg $8,833/year across 7 years
Top 3% in TX for pain medicine
28
Companies
922
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,559 (46.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,215 (37.5%)
Scientific / Research
Research funding and grants
$10,055 (16.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,678
2023
$3,690
2022
$5,728
2021
$5,430
2020
$3,151
2019
$13,025
2018
$1,128

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$23,906
SurGenTec
$20,103
Medtronic USA, Inc.
$10,055
Nevro Corp.
$2,676
Boston Scientific Corporation
$1,159
Relievant Medsystems, Inc.
$1,088
Spinal Simplicity, LLC
$636
Vertos Medical, Inc.
$564
Nalu Medical, Inc.
$353
Curonix LLC
$336
Stimwave Technologies Incorporated
$163
BOSTON SCIENTIFIC CORPORATION
$115
ABBVIE INC.
$107
Vertiflex, Inc.
$88
PAINTEQ LLC
$84
AbbVie Inc.
$83
MML US, Inc.
$52
Stryker Corporation
$40
SPR Therapeutics, Inc
$39
Bioventus LLC
$29
ARBOR PHARMACEUTICALS, INC.
$29
Avanos Medical
$25
Medtronic, Inc.
$23
Collegium Pharmaceutical, Inc.
$22
BioDelivery Sciences International, Inc.
$14
Allergan, Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$12
Top 3 companies account for 87.4% of total payments
Associated products mentioned in payments ›
Absolute Pro vascular stent system · BELBUCA · Belbuca · ETERNA · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · HA MINUTEMAN G3-R · Horizant · INTELLIS · Intracept · MILD DEVICE KIT · NT1100 NT2000iX Simplicity · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · Octrode SCS Leads · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROTG · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · ReActiv8 · SCS IPGs · SPECTRA WAVEWRITER · SPRINT PNS System · STANDARD RF DISPOSABLES · SUPARTZ FX SODIUM HYALURONATE · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · TiLink · UBRELVY · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (46%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for pain medicine in TX.

Equivalent to $1,096 per 100 Medicare services performed
Looking for a pain medicine specialist in Waco?
Compare pain medicines in the Waco area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
3
Per 100K population
1.1
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garitty is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with consulting-driven industry engagement in the top 3% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garitty experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Garitty performed 1,362 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garitty receive payments from pharmaceutical companies?
Yes. Dr. Garitty received a total of $61,830 from 28 companies across 922 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garitty's costs compare to other pain medicines in Waco?
Dr. Garitty's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garitty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →